Renal Denervation Mitigates Atherosclerosis in ApoE-/- Mice Via the Suppression of Inflammation

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2020 Oct 12

PMID 33042425

Citations 6

Authors

Han Chen

Rui Wang

Fei Xu

Tongtong Zang

Meng Ji

Jiasheng Yin

Jiahui Chen

Li Shen

Junbo Ge

Affiliations

Soon will be listed here.

Abstract

Atherosclerosis is a chronic pathological process characterized by the accumulation of inflammation. Overactivation of the sympathetic nervous system accelerates the progression of atherosclerosis. Renal denervation (RDN) reduces the activity of the sympathetic nerve system (SNS) by disrupting sympathetic nerves surrounding renal arteries. We sought to determine whether RDN could mitigate atherosclerosis through the suppression of inflammation. First, we investigated the correlation between plasma norepinephrine concentrations and circulatory inflammation in the progression of atherosclerosis. Then, forty ApoE-/- mice underwent renal denervation or a sham operation after 6 weeks or 12 weeks of feeding with a high-fat diet. The effects of RDN on atherosclerosis in mice were explored. In the development of atherosclerosis, positive correlations were found between SNS activation and the accumulation of circulatory myeloid cells and inflammatory cytokines. In the second part of the study, inhibition of the increase in plaque size was found in both RDN groups compared with that in the sham operation (SO) groups (P<0.05), and RDN also ameliorated inflammation in plaques. Furthermore, RDN attenuated the accumulation of circulating neutrophils and monocytes (P<0.05), which is associated with a significant reduction in levels of several circulating inflammatory cytokines related to hemopoiesis (P<0.05). Flow cytometry analysis revealed comparable levels of neutrophils and monocytes in the bone marrow between all four groups. However, RDN decreased the production and proportions of neutrophils and monocytes in the spleen and reduced splenic sympathetic activity (P<0.05). In summary, our study reveals a novel link between SNS activity and inflammation in atherosclerosis and identifies RDN as a potential anti-inflammatory therapeutic strategy for the treatment of atherosclerosis by restricting the production of splenic immune cells.

Citing Articles

Sympathetic Nervous System and Atherosclerosis.

Wang Y, Anesi J, Maier M, Myers M, Oqueli E, Sobey C Int J Mol Sci. 2023; 24(17).

PMID: 37685939 PMC: 10487841. DOI: 10.3390/ijms241713132.

Enhanced Peripheral Chemoreflex Drive Is Associated with Cardiorespiratory Disorders in Mice with Coronary Heart Disease.

Bravo L, Pereyra K, Diaz H, Flores M, Schwarz K, Toledo C Adv Exp Med Biol. 2023; 1427:99-106.

PMID: 37322340 DOI: 10.1007/978-3-031-32371-3_11.

Favorable effect of renal denervation on elevated renal vascular resistance in patients with resistant hypertension and type 2 diabetes mellitus.

Manukyan M, Falkovskaya A, Mordovin V, Pekarskiy S, Zyubanova I, Solonskaya E Front Cardiovasc Med. 2023; 9:1010546.

PMID: 36601066 PMC: 9806766. DOI: 10.3389/fcvm.2022.1010546.

The Effect of Renal Denervation on Cardiac Diastolic Function in Patients with Hypertension and Paroxysmal Atrial Fibrillation.

Xu H, Jiang Z, Jiang W, Huo J, Shan Q Evid Based Complement Alternat Med. 2022; 2022:2268591.

PMID: 35668773 PMC: 9167068. DOI: 10.1155/2022/2268591.

Immediate Renal Denervation After Acute Myocardial Infarction Mitigates the Progression of Heart Failure via the Modulation of IL-33/ST2 Signaling.

Chen H, Wang R, Li Q, Yin J, Ge Z, Xu F Front Cardiovasc Med. 2021; 8:746934.

PMID: 34660745 PMC: 8517399. DOI: 10.3389/fcvm.2021.746934.

References

van Diepen J, Berbee J, Havekes L, Rensen P . Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis. 2013; 228(2):306-15. DOI: 10.1016/j.atherosclerosis.2013.02.028. View

Azizi M, Schmieder R, Mahfoud F, Weber M, Daemen J, Davies J . Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018; 391(10137):2335-2345. DOI: 10.1016/S0140-6736(18)31082-1. View

Townsend R, Mahfoud F, Kandzari D, Kario K, Pocock S, Weber M . Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017; 390(10108):2160-2170. DOI: 10.1016/S0140-6736(17)32281-X. View

Al-Sharea A, Lee M, Whillas A, Michell D, Shihata W, Nicholls A . Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis. Haematologica. 2018; 104(3):456-467. PMC: 6395347. DOI: 10.3324/haematol.2018.192898. View

Jaiswal S, Libby P . Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol. 2019; 17(3):137-144. PMC: 9448847. DOI: 10.1038/s41569-019-0247-5. View

Vasamsetti S, Florentin J, Coppin E, Stiekema L, Zheng K, Nisar M . Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation. Immunity. 2018; 49(1):93-106.e7. PMC: 6051926. DOI: 10.1016/j.immuni.2018.05.004. View

Libby P . Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(9):2045-51. PMC: 3422754. DOI: 10.1161/ATVBAHA.108.179705. View

Baumer Y, McCurdy S, Weatherby T, Mehta N, Halbherr S, Halbherr P . Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun. 2017; 8(1):1129. PMC: 5654750. DOI: 10.1038/s41467-017-01186-z. View

Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins C . Myocardial infarction accelerates atherosclerosis. Nature. 2012; 487(7407):325-9. PMC: 3401326. DOI: 10.1038/nature11260. View

10.

Kleveland O, Kunszt G, Bratlie M, Ueland T, Broch K, Holte E . Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J. 2016; 37(30):2406-13. DOI: 10.1093/eurheartj/ehw171. View

11.

Stewart R, White H, Kirby A, Heritier S, Simes R, Nestel P . White blood cell count predicts reduction in coronary heart disease mortality with pravastatin. Circulation. 2005; 111(14):1756-62. DOI: 10.1161/01.CIR.0000160924.73417.26. View

12.

Xiao L, Kirabo A, Wu J, Saleh M, Zhu L, Wang F . Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension. Circ Res. 2015; 117(6):547-57. PMC: 4629828. DOI: 10.1161/CIRCRESAHA.115.306010. View

13.

Wang H, Wang J, Guo C, Luo W, Kleiman K, Eitzman D . Renal denervation attenuates progression of atherosclerosis in apolipoprotein E-deficient mice independent of blood pressure lowering. Hypertension. 2015; 65(4):758-65. PMC: 4776645. DOI: 10.1161/HYPERTENSIONAHA.114.04648. View

14.

Selejan S, Linz D, Tatu A, Hohl M, Speer T, Ewen S . Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome. J Mol Cell Cardiol. 2018; 122:34-46. DOI: 10.1016/j.yjmcc.2018.08.003. View

15.

Pavlov V, Tracey K . Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci. 2017; 20(2):156-166. DOI: 10.1038/nn.4477. View

16.

Wang J, Su E, Wang H, Guo C, Lawrence D, Eitzman D . Traumatic Brain Injury Leads to Accelerated Atherosclerosis in Apolipoprotein E Deficient Mice. Sci Rep. 2018; 8(1):5639. PMC: 5884790. DOI: 10.1038/s41598-018-23959-2. View

17.

Zaldivia M, Rivera J, Hering D, Marusic P, Sata Y, Lim B . Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk. Hypertension. 2016; 69(2):323-331. DOI: 10.1161/HYPERTENSIONAHA.116.08373. View

18.

Bohm M, Kario K, Kandzari D, Mahfoud F, Weber M, Schmieder R . Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020; 395(10234):1444-1451. DOI: 10.1016/S0140-6736(20)30554-7. View

19.

Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O . Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020; 17(6):327-340. DOI: 10.1038/s41569-019-0326-7. View

20.

Yamada S, Fong M, Hsiao Y, Chang S, Tsai Y, Lo L . Impact of Renal Denervation on Atrial Arrhythmogenic Substrate in Ischemic Model of Heart Failure. J Am Heart Assoc. 2018; 7(2). PMC: 5850156. DOI: 10.1161/JAHA.117.007312. View